A computer model that can support virtual clinical trials in the field of immuno-inflammation is the goal of a new collaboration between Bristol-Myers Squibb (BMS) and US-based healthcare analytics ...
And the disease model will aid in virtual clinical trials of sorts, using computer simulations to predict the potential impact of drugs in patients. With clinical and molecular data from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results